St. Louis, MO, United States of America

Adam Bloom

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Washington University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam Bloom. Retrieved from https://idiyas.com/inventor/adam-bloom-2jx0ok52

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Adam Bloom

Introduction

Adam Bloom is an accomplished inventor based in St. Louis, MO. He has made significant contributions to the field of neurobiology through his innovative research and patents. His work focuses on neurolytic agents and their applications, showcasing his expertise in this specialized area.

Latest Patents

Adam Bloom holds a patent for "Neurolytic agents and methods of using and identifying same." This patent includes the provision of a SARM1 activating agent or prodrug thereof, along with methods for utilizing these agents effectively. His innovative approach has the potential to advance the understanding and treatment of neurological conditions.

Career Highlights

Bloom is affiliated with Washington University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential impact on neurobiology and therapeutic applications.

Collaborations

Some of his notable coworkers include Jeffrey D. Milbrandt and Aaron Diantonio. Their collaborative efforts contribute to the advancement of research in neurolytic agents and related methodologies.

Conclusion

Adam Bloom's contributions to the field of neurobiology through his patent and research at Washington University highlight his role as an innovative inventor. His work continues to pave the way for advancements in understanding neurological conditions and developing effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…